Antimicrobial Expert Advisory Group

The Antimicrobial Expert Advisory Group (AmEAG) provides a source of expertise on antimicrobial stewardship, resistance, infection prevention and management and related issues which impact on the pharmacy profession and the public.

The AmEAG works closely with our Boards and other groups, providing expertise and advice on antimicrobial matters including:

  • advise on relevant national and international matters;
  • support with acting as a conduit for requests for advice, expertise, input and comment from government and other organisations;
  • where agreed, represent the RPS by providing expertise and leadership opinion aligned with our policy (where relevant). This may include attending meetings or acting as a media spokesperson;
  • provide a cohesive, strategic forum to ensure pharmacy is able to input and shape key policies and innovation around relevant matters;
  • provide a confidential forum for sharing intelligence, in order to support and inform those engaged in similar projects and work streams;
  • ensure a joined up approach across the RPS and the profession, including existing RPS groups, partners and  relevant external organisations;
  • support us in engaging all pharmacists and pharmacy teams in optimising use of antimicrobials to contribute to the AMR National Action Plan 2019-2024 and the 20-year Strategy.
  • support with the development of relevant services and resources to support the membership and the profession, including training programmes, events, webinars, quick reference guides, toolkits, etc.

Member specification

Membership of the group is based on an individual’s own professional experience rather than them being representative of another group or their organisation. Members of the group will:

  • Be nationally and ideally internationally recognised as an expert in antimicrobials (nominees should be at the forefront of antimicrobial expertise from all sectors).
  • Have a high level of involvement in institutional roles and professional organisations.
  • Have a high professional standing and reputation. It is desirable that members have been recognised by the RPS Faculty or are working towards recognition.
  • Possess a broad knowledge and expertise in antimicrobial pharmacy and/or multidisciplinary experience and expertise.
  • Have a high level of organisational leadership and management skills
  • Be a member of the RPS. Members of the group are expected to conform to the RPS code of conduct for members of governance bodies as well as codes applicable to their respective disciplines and institutions. Members should not be a member of any other RPS Advisory Group.
  • Members will be expected to declare any conflicts of interest, and to act in an open and transparent manner without undue influence.

What we're working on

HEE Innovation fund AMR training program

This 100 day program will help the development of 30 Post-Foundation pharmacists working in NHS acute trusts and CCGs in London and South East England; aligned to the RPS National Training Program structure, it will include self-directed e-learning, a face to face training day, practice-based feedback and a final portfolio review. Pharmacists completing this training will be awarded a certificate of completion.

Other work

  • NICE consultation: Community-acquired pneumonia antimicrobial prescribing guideline (Mar 2019)
  • Support Commonwealth Partnerships for Antimicrobial Stewardship Scheme (Jan 2019)
  • Advice on endorsement request: UTI diagnostic flowchart (Nov 2018)


Chair: Jacqueline Sneddon

  • Diane Ashiru Oredope
  • Elizabeth Beech
  • Alison Cockburn
  • Mark Gilchrist
  • Cairine Gormley
  • Kieran Hand
  • Diane Harris
  • Philip Howard
  • Ceri Phillips
  • Nick Reid
  • Tushar Shah
  • Tracey Thornley
  • Paul Wade
  • Laura Whitney
  • Hayley Wickens